🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
92.49
+0.54 (0.59%)
At close: Nov 18, 2026, 4:00 PM EST
92.60
+0.11 (0.12%)
After-hours: Nov 18, 2026, 4:32 PM EST

Mirum Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-903.88-23.36-87.94-163.42-135.67-83.99
Depreciation & Amortization
26.7724.2423.6310.833.240.6
Other Amortization
2.41.741.661.12--
Loss (Gain) From Sale of Assets
------108
Loss (Gain) From Sale of Investments
------0.14
Stock-Based Compensation
119.1171.4248.4435.0227.0123.09
Other Operating Activities
425.371.51.9464.726.3318.7
Change in Accounts Receivable
-58.7-48.06-11.43-43.97-20.73-
Change in Inventory
-4.7-8.45-3.17-0.97-3.45-0.5
Change in Accounts Payable
70.8250.140.3130.787.6422.66
Change in Other Net Operating Assets
51.54-13.32-3.13-5.05-4.51-5.18
Operating Cash Flow
-271.2655.8310.33-70.94-120.14-132.76
Operating Cash Flow Growth
-440.70%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.59-0.95-0.99-0.11-0.28-0.02
Cash Acquisitions
----212.76--
Sale (Purchase) of Intangibles
-35--20-20--19
Investment in Securities
-161.83-23-69.13125.677.98-40.43
Other Investing Activities
-----108
Investing Cash Flow
-199.42-23.95-90.13-107.27.748.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---305.3--
Total Debt Issued
672.05--305.3--
Net Debt Issued (Repaid)
135.97--305.3--
Issuance of Common Stock
308.8140.1417.7227.15114.649.01
Other Financing Activities
-8.6---195.86-5.5564.45
Financing Cash Flow
436.1740.1417.7336.6109.0973.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.073.22-1.3-0.130.01-0
Net Cash Flow
-37.5875.24-63.4158.32-3.34-10.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-273.8554.879.33-71.05-120.41-132.78
Free Cash Flow Growth
-488.01%----
Free Cash Flow Margin
-40.83%10.53%2.77%-38.12%-156.26%-693.81%
Free Cash Flow Per Share
-4.581.090.20-1.74-3.54-4.38
Levered Free Cash Flow
98.3998.5616.67-91.35-68.57-96.18
Unlevered Free Cash Flow
103.14105.8123.95-83.03-58.59-85.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.3312.6512.656.82--
Cash Income Tax Paid
3.292.1610.13--
Change in Working Capital
58.96-19.7222.59-19.22-21.0516.98
SEC Filings: 10-K · 10-Q